ArticleFrontiers in cell and developmental biology2025

Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma.

Wuyang Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.